Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,165 | 10,615 | 13,311 | 10,061 | 11,500 |
| TOTAL | $57,940 | $11,386 | $13,952 | $10,474 | $12,193 |
| Non-Current Assets | |||||
| PPE Net | 356 | 435 | 543 | 245 | 1,444 |
| Intangibles | 0 | 0 | 0 | 1,676 | 1,676 |
| Other Non-Current Assets | 364 | 430 | 559 | 478 | 12 |
| TOTAL | $720 | $865 | $1,102 | $2,398 | $3,131 |
| Total Assets | $58,659 | $12,251 | $15,054 | $12,872 | $15,325 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,443 | 2,664 | 1,544 | 1,868 | 1,416 |
| Other current liabilities | N/A | N/A | 43 | 105 | 127 |
| TOTAL | $3,563 | $2,770 | $1,622 | $2,115 | $1,633 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 33 | 139 | N/A |
| Other Non-Current Liabilities | 302 | 422 | 171 | 0 | 147 |
| TOTAL | $302 | $422 | $171 | $2 | $152 |
| Total Liabilities | $3,865 | $3,191 | $1,793 | $2,117 | $1,785 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 168 | 31 | 16 | 6 | 4 |
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -126,775 | -111,681 | -97,588 | -84,349 | -70,787 |
| Other shareholders' equity | 18,888 | 0 | 0 | 0 | 0 |
| TOTAL | $54,795 | $9,059 | $13,261 | $10,755 | $13,540 |
| Total Liabilities And Equity | $58,659 | $12,251 | $15,054 | $12,872 | $15,325 |